Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/5074
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVidya Jyothi Alli-
dc.date.accessioned2026-06-03T11:00:00Z-
dc.date.available2026-06-03T11:00:00Z-
dc.date.issued2026-06-03-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/5074-
dc.descriptionVol. 64 No. 1, p 22en_US
dc.language.isoenen_US
dc.subjectDynamicsen_US
dc.subjectIn silico ADMET studyen_US
dc.subjectIn silico target predictionen_US
dc.subjectPharmacophoreen_US
dc.subjectRosiglitazoneen_US
dc.titleLigand based pharmacophoric discovery of new CLK1 inhibitorsen_US
dc.typeOtheren_US
Appears in Collections:Vol. 64 No. 1, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 64 No. 1, p 22101.17 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.